Literature DB >> 31813080

Adipokines: New Therapeutic Target for Osteoarthritis?

Chenxi Xie1, Qian Chen2.   

Abstract

PURPOSE OF THE REVIEW: Osteoarthritis (OA) is an aging-associated and injury-induced joint disease characterized by cartilage degradation, bone sclerosis, and persistent low-grade inflammation in the joint. Aging and injury are triggers of joint pathological changes mediated by pro-inflammatory factors, some of which are secreted by white adipose tissue. Adipokines including adiponectin, leptin, resistin, chemerin, IL-6, and TNF-α are major players not only during inflammation but also in metabolic regulation of joint cells including chondrocytes, osteoblasts, osteoclasts as well as mesenchymal stem cells. The purpose of this review is to summarize the signal transduction pathways of adipokines in the articular joint to provide new information on potential targets for intervention of OA. RECENT
FINDINGS: The risk of knee osteoarthritis is associated with adipokine gene polymorphism. While the infrapatellar fat pad is a major source of adipokines in knee synovial fluid, adipocytes also accumulate in the bone marrow during aging and obesity. Adipokines can act as SASPs (senescence associated secretory phenotype factors) that participate in cellular senescence of chondrocytes, but they also regulate energy metabolism impacting bone remodeling. Thus, adipokines are closely related to the metabolic syndrome and degenerative pathological changes in cartilage and bone during OA. Modulating the effects of adipokines on different cell types in the intra-articular joint will be a promising new option for OA intervention.

Entities:  

Keywords:  Adipokine; Bone cells; Chondrocytes; Osteoarthritis; SASPs

Year:  2019        PMID: 31813080      PMCID: PMC7291783          DOI: 10.1007/s11926-019-0868-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  80 in total

1.  gp130 dimerization in the absence of ligand: preformed cytokine receptor complexes.

Authors:  Stephanie Tenhumberg; Björn Schuster; Lixin Zhu; Marina Kovaleva; Jürgen Scheller; Karl-Josef Kallen; Stefan Rose-John
Journal:  Biochem Biophys Res Commun       Date:  2006-06-06       Impact factor: 3.575

2.  The fat on the joint: osteoarthritis and obesity.

Authors:  T D Spector
Journal:  J Rheumatol       Date:  1990-03       Impact factor: 4.666

3.  Role and mechanism of PTEN in adiponectin-induced osteogenesis in human bone marrow mesenchymal stem cells.

Authors:  Xuhong Liu; Tong Chen; Yuwei Wu; Zhihui Tang
Journal:  Biochem Biophys Res Commun       Date:  2016-12-13       Impact factor: 3.575

4.  Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes.

Authors:  Fatima Ezzahra El Mansouri; Nadir Chabane; Nadia Zayed; Mohit Kapoor; Mohamed Benderdour; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Nicolas Duval; Hassan Fahmi
Journal:  Arthritis Rheum       Date:  2011-01

5.  Association of chemerin levels in synovial fluid with the severity of knee osteoarthritis.

Authors:  Ke Huang; Gang Du; Lin Li; Hongsuo Liang; Bo Zhang
Journal:  Biomarkers       Date:  2011-11-14       Impact factor: 2.658

6.  TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways.

Authors:  Cheryle A Séguin; Suzanne M Bernier
Journal:  J Cell Physiol       Date:  2003-12       Impact factor: 6.384

Review 7.  Adiponectin receptor as a key player in healthy longevity and obesity-related diseases.

Authors:  Toshimasa Yamauchi; Takashi Kadowaki
Journal:  Cell Metab       Date:  2013-01-24       Impact factor: 27.287

8.  Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

Authors:  T Tamura; N Udagawa; N Takahashi; C Miyaura; S Tanaka; Y Yamada; Y Koishihara; Y Ohsugi; K Kumaki; T Taga
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

9.  Chemokine-like receptor 1 deficiency leads to lower bone mass in male mice.

Authors:  Huashan Zhao; Dewen Yan; Liang Xiang; Chen Huang; Jian Li; Xiangfang Yu; Binbin Huang; Baobei Wang; Jie Chen; Tianxia Xiao; Pei-Gen Ren; Jian V Zhang
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

10.  Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration.

Authors:  Thomas H Ambrosi; Antonio Scialdone; Antonia Graja; Sabrina Gohlke; Anne-Marie Jank; Carla Bocian; Lena Woelk; Hua Fan; Darren W Logan; Annette Schürmann; Luis R Saraiva; Tim J Schulz
Journal:  Cell Stem Cell       Date:  2017-03-16       Impact factor: 24.633

View more
  37 in total

1.  Global Burden of osteoarthritis associated with high body mass index in 204 countries and territories, 1990-2019: findings from the Global Burden of Disease Study 2019.

Authors:  Gaichan Zhao; Shijie Zhu; Faxue Zhang; Xupeng Zhang; Xiaowei Zhang; Tianzhou Li; Dejia Li; Wei Zhu
Journal:  Endocrine       Date:  2022-10-03       Impact factor: 3.925

Review 2.  Obesity, Inflammation, and Immune System in Osteoarthritis.

Authors:  Udhaya Nedunchezhiyan; Ibin Varughese; Antonia RuJia Sun; Xiaoxin Wu; Ross Crawford; Indira Prasadam
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 3.  Adiponectin, May Be a Potential Protective Factor for Obesity-Related Osteoarthritis.

Authors:  Hai Jiang; Yu Pu; Zeng-Hui Li; Wei Liu; Yan Deng; Rui Liang; Xiao-Ming Zhang; Hou-Dong Zuo
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-27       Impact factor: 3.249

4.  Adipose tissue is a critical regulator of osteoarthritis.

Authors:  Kelsey H Collins; Kristin L Lenz; Eleanor N Pollitt; Daniel Ferguson; Irina Hutson; Luke E Springer; Arin K Oestreich; Ruhang Tang; Yun-Rak Choi; Gretchen A Meyer; Steven L Teitelbaum; Christine T N Pham; Charles A Harris; Farshid Guilak
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

5.  Amidation-Modified Apelin-13 Regulates PPARγ and Perilipin to Inhibit Adipogenic Differentiation and Promote Lipolysis.

Authors:  Sha Wang; Guoying Gao; Yiwei He; Qiong Li; Zhan Li; Guoxiang Tong
Journal:  Bioinorg Chem Appl       Date:  2021-05-07       Impact factor: 7.778

Review 6.  Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!

Authors:  Francesca Coperchini; Luca Chiovato; Mario Rotondi
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

Review 7.  Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication.

Authors:  Gashaw Dessie; Birhanu Ayelign; Yonas Akalu; Tewodros Shibabaw; Meseret Derbew Molla
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-17       Impact factor: 3.168

8.  Identification and validation of key long non-coding RNAs in resveratrol protect against IL-1β-treated chondrocytes via integrated bioinformatic analysis.

Authors:  Hong Yi; Wei Zhang; Sheng-Yu Cui; Jian-Bo Fan; Xin-Hui Zhu; Wei Liu
Journal:  J Orthop Surg Res       Date:  2021-07-02       Impact factor: 2.359

9.  Equine Mesenchymal Stem/Stromal Cells Freeze-Dried Secretome (Lyosecretome) for the Treatment of Musculoskeletal Diseases: Production Process Validation and Batch Release Test for Clinical Use.

Authors:  Michela Mocchi; Stefano Grolli; Silvia Dotti; Dario Di Silvestre; Riccardo Villa; Priscilla Berni; Virna Conti; Giulia Passignani; Francesca Brambilla; Maurizio Del Bue; Laura Catenacci; Milena Sorrenti; Lorena Segale; Elia Bari; Pierluigi Mauri; Maria Luisa Torre; Sara Perteghella
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-10

10.  Exploring the Crosstalk between Hydrostatic Pressure and Adipokines: An In Vitro Study on Human Osteoarthritic Chondrocytes.

Authors:  Sara Cheleschi; Sara Tenti; Marcella Barbarino; Stefano Giannotti; Francesca Bellisai; Elena Frati; Antonella Fioravanti
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.